Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Digging into the Phase 2 RISE UP data on Agio's PYRUKYND (mitapivat) in patients with sickle cell disease

Ticker(s): AGIO

Who's the expert?

Institution: Private Practice

Professor Emerita of Medicine and Pediatrics, Albert Einstein College of medicine and former Director of the Sickle Cell Center for Adults at Montefiore Medical Center
Treats 30 patients with sickle cell
Research focuses on understanding mechanisms that lead to end organ damage in order to identify early biomarkers and targeted therapies

Interview Goal

To discuss the standard of care and the potential of PYRUKYND (mitapivat), a pyruvate kinase activator being developed by Agio Pharmaceuticals for the treatment of sickle cell disease.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.